Cargando…

Role of viral and host factors in interferon based therapy of hepatitis C virus infection

The current standard of care (SOC) for hepatitis C virus (HCV) infection is the combination of pegylated interferon (PEG-IFN), Ribavirin and protease inhibitor for HCV genotype 1. Nevertheless, this treatment is successful only in 70-80% of the patients. In addition, the treatment is not economical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imran, Muhammad, Manzoor, Sobia, Ashraf, Javed, Khalid, Madiha, Tariq, Muqddas, Khaliq, Hafiza Madeha, Azam, Sikandar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849893/ https://www.ncbi.nlm.nih.gov/pubmed/24079723 http://dx.doi.org/10.1186/1743-422X-10-299

Ejemplares similares

Interaction of Hepatitis C virus proteins with pattern recognition receptors
por: Imran, Muhammad, et al.
Publicado: (2012)

Hepatitis C Virus Infection: Molecular Pathways to Insulin resistance
por: Parvaiz, Fahed, et al.
Publicado: (2011)

P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis
por: Manzoor, Sobia, et al.
Publicado: (2022)

Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, Pakistan
por: Kanwal, Sobia, et al.
Publicado: (2012)

Antioxidants and Calcium Modulators Preclude in Vitro Hepatitis B Virus–Induced Mitochondrial Damage
por: Jabeen, Kehkshan, et al.
Publicado: (2023)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
por: Akram, Madiha, et al.
Publicado: (2011)

In-Vitro Transcription analysis of NS5A from HCV-3a circulating in Pakistani patients with chronic hepatitis C and their differential response to antiviral therapy
por: Bhatti, Shameem, et al.
Publicado: (2017)

Nucleotide identity and variability among different Pakistani hepatitis C virus isolates
por: Idrees, Muhammad, et al.
Publicado: (2009)

Association of laboratory parameters with viral factors in patients with hepatitis C
por: Ijaz, Bushra, et al.
Publicado: (2011)

Hepatitis C virus to hepatocellular carcinoma
por: Jahan, Shah, et al.
Publicado: (2012)

Molecular epidemiology and clinical features of Hepatitis C Virus (HCV) in epidemic areas of Interior Sindh, Pakistan
por: Bhatti, Shameem, et al.
Publicado: (2016)

Transcriptional Analysis of TP53 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon, and Ribavirin
por: Chudhary, Hafiza Rida Farooq, et al.
Publicado: (2023)

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin
por: Asselah, Tarik, et al.
Publicado: (2010)

Bovine viral diarrhea virus in China: A comparative genomic and phylogenetic analysis with complete genome sequences
por: Shah, Pir Tariq, et al.
Publicado: (2022)

Clinical and Epidemiological Spectrum of Acute Viral Hepatitis Due to Hepatitis A and E in Children: A Descriptive, Cross-Sectional, Hospital-Based Study
por: Rasheed, Javaria, et al.
Publicado: (2022)

LEUKOCYTES AND INTERFERON IN THE HOST RESPONSE TO VIRAL INFECTIONS : I. MOUSE LEUKOCYTES AND LEUKOCYTE-PRODUCED INTERFERON IN VACCINIA VIRUS INFECTION IN VITRO
por: Glasgow, Lowell A.
Publicado: (1965)

Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes
por: Chaturvedi, Nimisha, et al.
Publicado: (2019)

Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence
por: Chigbu, DeGaulle I., et al.
Publicado: (2019)

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
por: Huang, Yi-Wen, et al.
Publicado: (2022)

Viral hijacking of the host ubiquitin system to evade interferon responses
por: Viswanathan, Kasinath, et al.
Publicado: (2010)

Expanding the Host Range of Hepatitis C Virus through Viral Adaptation
por: von Schaewen, Markus, et al.
Publicado: (2016)

Hepatitis B virus–host interactions and novel targets for viral cure
por: Ligat, Gaëtan, et al.
Publicado: (2021)

Host Innate Immunity Against Hepatitis Viruses and Viral Immune Evasion
por: Xu, Chonghui, et al.
Publicado: (2021)

Phylogenetic analysis of torque teno virus genome from Pakistani isolate and incidence of co-infection among HBV/HCV infected patients
por: Hussain, Tabinda, et al.
Publicado: (2012)

Inhibition of full length Hepatitis C Virus particles of 1a genotype through small interference RNA
por: Ansar, Muhammad, et al.
Publicado: (2011)

Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection
por: Gull, Iram, et al.
Publicado: (2019)

Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection
por: Wang, Jiayi, et al.
Publicado: (2021)

Envelope 2 protein phosphorylation sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: A sequence alignment approach
por: Afzal, Samia, et al.
Publicado: (2011)

Awareness and safe practices of Hepatitis-B and C prevention and transmission among workers of women beauty salons
por: Bashir, Hafiza Hifza, et al.
Publicado: (2022)

Interferon lambda 4 expression is suppressed by the host during viral infection
por: Hong, MeeAe, et al.
Publicado: (2016)

Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy
por: Akram, Madiha, et al.
Publicado: (2011)

Exploitation of Lipid Components by Viral and Host Proteins for Hepatitis C Virus Infection
por: Moriishi, Kohji, et al.
Publicado: (2012)

The myth of oral hygiene using synthetic mouthwash products
por: Jahangir, Ghulam Zahara, et al.
Publicado: (2016)

Antiviral drugs against hepatitis C virus
por: Rehman, Sidra, et al.
Publicado: (2011)

Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a
por: Manzoor, Sobia, et al.
Publicado: (2011)

Interferon Induction by RNA Viruses and Antagonism by Viral Pathogens
por: Nan, Yuchen, et al.
Publicado: (2014)

Carcinoma-specific expression of P2Y(11) receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells
por: Khalid, Madiha, et al.
Publicado: (2017)

Natural Products Mediated Targeting of Virally Infected Cancer
por: Fatima, Iram, et al.
Publicado: (2019)

Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling
por: Sugiyama, Ryuichi, et al.
Publicado: (2017)

When Hepatitis B Virus Meets Interferons
por: Tan, Guangyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ni4biipnpj926o2bij7unadnki